Shift Biosciences announces key appointments to advance rejuvenation therapeutics pipeline

FHS
March 12, 2025
10:50 am

Shift Biosciences, a biotech company using an AI powered virtual cell to fight age-related diseases, today announced the appointments of Jill Reckless, Ph.D, as Translation Advisor and Laurence Reid, Ph.D., as Non-Executive Director. In these roles, Jill and Laurence will guide Shift in building a robust product translation and business development strategy respectively, enabling the Company to capitalize on early momentum and progress its pipeline of novel rejuvenation therapeutics towards clinical development.

Exactech files for Chapter 11, agrees to investor buyout

Dive Brief: Exactech has filed for Chapter 11 bankruptcy protection and agreed to sell its assets to existing investors, the company said Tuesday. The bankruptcy

October 30, 2024

Neuroscience legend Steve Paul retires; Exclusive: GSK hires ex-Innate Pharma CEO for new position

If you’re in neuroscience, you’ve probably heard of him. Few people have dipped a hand in as many neuroscience biotechs and government research units as

January 20, 2024

New facile strategy for proteome analysis using ultracentrifugation fractionation

Urine is one of the attractive sources for early and sensitive biomarker discovery since it can accumulate and reflect changes in the human body while

June 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.